<sup>18</sup>F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center
Purpose: To describe the initial experience of an academic center using <sup>18</sup>F-DCFPyL PET in managing men with recurrent prostate cancer. Materials & Methods: This prospective, single-arm IRB-approved study included men with biochemical failure after primary therapy for prost...
Main Authors: | Ur Metser, Claudia Ortega, Douglas Hussey, Rosanna Chan, Alejandro Berlin, Antonio Finelli, Patrick Veit-Haibach |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/28/5/282 |
Similar Items
-
18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study
by: Ur Metser, et al.
Published: (2022-10-01) -
Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on <sup>18</sup>F-DCFPyL PET/CT Scans
by: Tushar Garg, et al.
Published: (2022-10-01) -
Salivary excretion of systemically injected [18F]DCFPyL in prostate cancer patients undergoing PSMA scans
by: Bruna Fernandes, et al.
Published: (2024-04-01) -
Higher Preoperative Maximum Standardised Uptake Values (SUV<sub>max</sub>) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]DCFPyL Positron Emission Tomography/Computed Tomography
by: Katelijne C. C. de Bie, et al.
Published: (2023-07-01) -
Evaluation of 18F-DCFPyL PSMA PET/CT for Prostate Cancer: A Meta-Analysis
by: Ke-Hao Pan, et al.
Published: (2021-02-01)